摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-cyclopropyl-6,7-bis((4-methoxybenzyl)oxy)-3-(pyrrolidin-1-ylmethyl)quinolin-4(1H)-one | 1429439-98-4

中文名称
——
中文别名
——
英文名称
1-cyclopropyl-6,7-bis((4-methoxybenzyl)oxy)-3-(pyrrolidin-1-ylmethyl)quinolin-4(1H)-one
英文别名
1-Cyclopropyl-6,7-bis[(4-methoxyphenyl)methoxy]-3-(pyrrolidin-1-ylmethyl)quinolin-4-one
1-cyclopropyl-6,7-bis((4-methoxybenzyl)oxy)-3-(pyrrolidin-1-ylmethyl)quinolin-4(1H)-one化学式
CAS
1429439-98-4
化学式
C33H36N2O5
mdl
——
分子量
540.659
InChiKey
YLFRPCAPPMVIPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    40
  • 可旋转键数:
    11
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    60.5
  • 氢给体数:
    0
  • 氢受体数:
    7

文献信息

  • [EN] ANTIBACTERIAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIBACTÉRIENS
    申请人:GLAXO GROUP LTD
    公开号:WO2013052568A1
    公开(公告)日:2013-04-11
    The present Invention relates to cephalosporin antibacterial compounds of Formula (!): corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods for bacterial infections, especially those caused by gram-negative bacteria.
    本发明涉及头孢菌素抗菌化合物的公式(I):以及相应的药学上可接受的盐、相应的药物组合物、化合物制备和治疗细菌感染的方法,特别是由革兰氏阴性细菌引起的感染。
  • [EN] 2 SUBSTITUTED CEPHEM COMPOUNDS<br/>[FR] COMPOSÉS DE CÉPHEM SUBSTITUÉS EN POSITION 2
    申请人:GLAXO GROUP LTD
    公开号:WO2014068388A1
    公开(公告)日:2014-05-08
    The compounds of formula (I) of the subject invention are related to 2-substituted cephem compounds, which have a wide antimicrobial spectrum, in particular exhibit potent antimicrobial activity against beta-lactamase producing Gram negative bacteria, and pharmaceutical compositions comprising the same.
    本发明的化学式(I)的化合物与2-取代头孢菌素类化合物相关,具有广泛的抗微生物谱,特别对产β-内酰胺酶的革兰氏阴性细菌表现出强效的抗微生物活性,并且包含这些化合物的药物组合物。
  • ANTIBACTERIAL COMPOUNDS
    申请人:GLAXO GROUP LIMITED
    公开号:US20140249126A1
    公开(公告)日:2014-09-04
    The present invention relates to cephalosporin antibacterial compounds of Formula (I): or corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods for bacterial infections, especially those caused by gram-negative bacteria.
    本发明涉及式(I)的头孢菌素抗菌化合物:或其相应的药学上可接受的盐,相应的制药组合物,化合物制备和治疗细菌感染的方法,特别是由革兰氏阴性菌引起的感染。
  • 2-SUBSTITUTED CEPHEM COMPOUNDS
    申请人:GLAXO GROUP LIMITED
    公开号:US20150299223A1
    公开(公告)日:2015-10-22
    The present invention relates to 2-substituted cephem compounds of Formula (I) having a quaternary ammonium group on the 3-side chain, preferably together with a cathechol group, or pharmaceutically acceptable salts thereof, which exhibit potent antimicrobial spectrum against a variety of bacteria including Gram negative bacteria and/or Gram positive bacteria, corresponding pharmaceutical compositions, methods of making, treatment methods for bacterial infections or uses thereof.
    本发明涉及具有第3侧链上季基团的2-取代头孢菌素化合物(I), 与儿茶酚基团一起更佳,或其药学上可接受的盐,对包括革兰氏阴性菌和/或革兰氏阳性菌在内的多种细菌具有强效的抗微生物谱,相应的制药组合物,制备方法,治疗细菌感染的方法或其用途。
  • 2 substituted cephem compounds
    申请人:Glaxo Group Limited
    公开号:US10174053B2
    公开(公告)日:2019-01-08
    The compounds of the subject invention are related to 2-substituted cephem compounds, which have a wide antimicrobial spectrum, in particular exhibit potent antimicrobial activity against beta-lactamase producing Gram negative bacteria, and pharmaceutical compositions comprising the same.
    本发明的化合物与 2-取代的头孢化合物有关,它们具有广泛的抗菌谱,特别是对β-内酰胺酶产生的革兰氏阴性菌具有强效抗菌活性,以及包含这些化合物的药物组合物。
查看更多